1-8 of 8
Richard M. Stone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

Available to Purchase
Evan C. Chen, Helen Gandler, Isidora Tošić, Geoffrey G. Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J. DeAngelo, Ilene Galinsky, Marlise R. Luskin, Martha Wadleigh, Eric S. Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna Neuberg, A. Thomas Look, Richard M. Stone, David A. Frank, Jacqueline S. Garcia
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (5): 878–887.
https://doi.org/10.1158/1078-0432.CCR-22-2540
Published: 01 March 2023
View articletitled, Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
Open the PDF for Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates in another window
Includes: Supplementary data
Journal Articles

Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia

Free
Christopher J. Walker, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, Krzysztof Mrózek, Sandya Liyanarachchi, Chi Song, Deedra Nicolet, James S. Blachly, Marius Bill, Dimitrios Papaioannou, Christopher C. Oakes, Brian Giacopelli, Luke K. Genutis, Sophia E. Maharry, Shelley Orwick, Kellie J. Archer, Bayard L. Powell, Jonathan E. Kolitz, Geoffrey L. Uy, Eunice S. Wang, Andrew J. Carroll, Richard M. Stone, John C. Byrd, Albert de la Chapelle, Clara D. Bloomfield
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (21): 6524–6531.
https://doi.org/10.1158/1078-0432.CCR-19-0725
Published: 01 November 2019
View articletitled, Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia
Open the PDF for Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Abstract 39: XPO1 inhibitor, KPT-8602, is well tolerated and highly active against AML blasts and LICs

Free
Julia Etchin, Alla Berezovskaya, Amy S. Conway, Ilene A. Galinsky, Richard M. Stone, Erkan Baloglu, William Senapedis, Yosef Landesman, Michael Kauffman, Sharon Shacham, Jean CY Wang, A Thomas Look
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24_Supplement): 39.
https://doi.org/10.1158/1557-3265.HEMMAL17-39
Published: 14 December 2017
View articletitled, Abstract 39: XPO1 inhibitor, KPT-8602, is well tolerated and highly active against AML blasts and LICs
Journal Articles

Blinatumomab for the Treatment of Philadelphia Chromosome–Negative, Precursor B-cell Acute Lymphoblastic Leukemia

Free
Ofir Wolach, Richard M. Stone
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (19): 4262–4269.
https://doi.org/10.1158/1078-0432.CCR-15-0125
Published: 30 September 2015
View articletitled, Blinatumomab for the Treatment of Philadelphia Chromosome–Negative, Precursor B-cell Acute Lymphoblastic Leukemia
Open the PDF for Blinatumomab for the Treatment of Philadelphia Chromosome–Negative, Precursor B-cell Acute Lymphoblastic Leukemia in another window
Journal Articles

Mutated BCR-ABL Generates Immunogenic T-cell Epitopes in CML Patients

Free
Ann Cai, Derin B. Keskin, David S. DeLuca, Anselmo Alonso, Wandi Zhang, Guang Lan Zhang, Naa Norkor Hammond, Valentina Nardi, Richard M. Stone, Donna Neuberg, John Sidney, Vladimir Brusic, Catherine J. Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (20): 5761–5772.
https://doi.org/10.1158/1078-0432.CCR-12-1182
Published: 14 October 2012
View articletitled, Mutated BCR-ABL Generates Immunogenic T-cell Epitopes in CML Patients
Open the PDF for Mutated BCR-ABL Generates Immunogenic T-cell Epitopes in CML Patients in another window
Includes: Supplementary data
Journal Articles

Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia

Free
Eyal C. Attar, Daniel J. DeAngelo, Jeffrey G. Supko, Ferdinando D'Amato, David Zahrieh, Andres Sirulnik, Martha Wadleigh, Karen K. Ballen, Steve McAfee, Kenneth B. Miller, James Levine, Ilene Galinsky, Elizabeth G. Trehu, David Schenkein, Donna Neuberg, Richard M. Stone, Philip C. Amrein
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1446–1454.
https://doi.org/10.1158/1078-0432.CCR-07-4626
Published: 03 March 2008
View articletitled, Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia
Open the PDF for Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia in another window
Journal Articles

Fifty Years of Clinical Research by the Leukemia Committee of the Cancer and Leukemia Group B

Free
Richard A. Larson, Richard M. Stone, Robert J. Mayer, Charles A. Schiffer
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (11): 3556s–3563s.
https://doi.org/10.1158/1078-0432.CCR-06-9001
Published: 01 June 2006
View articletitled, Fifty Years of Clinical Research by the Leukemia Committee of the Cancer and Leukemia Group B
Open the PDF for Fifty Years of Clinical Research by the Leukemia Committee of the Cancer and Leukemia Group B in another window
Journal Articles

Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation: Durable Cytogenetic Remission and Conversion to Complete Donor Chimerism without Graft- versus -Host Disease

Free
Daniel J. DeAngelo, Ephraim P. Hochberg, Edwin P. Alyea, Janina Longtine, Stephanie Lee, Ilene Galinsky, Ben Parekkedon, Jerome Ritz, Joseph H. Antin, Richard M. Stone, Robert J. Soiffer
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (15): 5065–5071.
https://doi.org/10.1158/1078-0432.CCR-03-0580
Published: 05 August 2004
View articletitled, Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation: Durable Cytogenetic Remission and Conversion to Complete Donor Chimerism without Graft- versus -Host Disease
Open the PDF for Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation: Durable Cytogenetic Remission and Conversion to Complete Donor Chimerism without Graft- versus -Host Disease in another window